In a new study led by researchers at Karolinska Institutet in Sweden, AI models did a better job of detecting ovarian cancer ...

A phase 1 trial evaluating FSHR-targeting CAR T cells for patients with ovarian cancer has dosed the first patient in its ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Discover crucial early warning signs of ovarian cancer that may surface during or after meals. Learn about symptoms, risk ...

AI can outperform human doctors when it comes to identifying ovarian cancer from ultrasound images.A new study publishe ...

Muzastotug is under clinical development by Adagene Suzhou and currently in Phase II for Metastatic Ovarian Cancer.

Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation (CDE) of the National ...

The top 5 ovarian cancer articles of 2024 covered topics such as the impact of air pollution on ovarian cancer risk, treatment strategies for patients with liver metastases, and the benefits of early ...

Can chronic constipation indicate cancer? Learn how to recognize warning signs, take early action, and protect your health.

An NDA has been accepted by the FDA for the combination of avutometinib and defactinib in KRAS-mutated recurrent low-grade ...